The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...

Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...

Living in a world with limited sight can cause some serious misunderstanding. Spend 59 seconds with Pete to hear about this ...

Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced its chief executive officer, Gregory D. Kunst, will present preclinical data highlighting the ...

The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for ...

Vision care for Canada’s Indigenous population is marked by the absence of early disease detection, accessible services, and ...

Could a virtual reality headset offer a cheaper, easier, and more comfortable method of testing a person's vision, ...

New Zealanders living with multiple sclerosis, breast cancer, eye conditions, and lung cancer will benefit from five medicines that Pharmac will fund from 1 December 2025.

Lowell Knobloch interviewed Mitchell resident William Thompson as part of his mission to preserve veterans’ stories ...